Join
Live feed
·
INSIDERFilingvia Quantisnow
Vallon Pharmaceuticals Inc. logo

SEC Form 4: Thorell Marella disposed of 28,517 shares, decreasing direct ownership by 75% to 9,506 units

ByQuantisnow·Wall Street's wire, on your screen.
VLON· Vallon Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VLON (Vallon Pharmaceuticals Inc.) and more on Quantisnow.